Bum Steer: Long Term Care Pharmacies Take CMS to Court Over "Steering"
This article was originally published in RPM Report
Nursing home pharmacy providers finally have some advocates: a First Amendment law firm is suing CMS on their behalf. Providers want to be able to recommend specific Part D plans to their patients. A victory would have a big impact on Part D formularies.
You may also be interested in...
FDA's Unlikely Defenders
The primacy of FDA-approved labeling has an unlikely advocate. The Washington Legal Foundation is joining the EPO coverage dispute to tell CMS not to step into FDA’s turf.
Are Long Term Care Rebates Dangerous?
One CMS official thinks it is time for a new business model in long term care. Eliminating rebates to long-term care providers may be necessary to protect patients and Part D plans.
Competing Priorities: Alzheimer's Drugs and the Delicate Balance that Defines Part D
The Alzheimer’s Association waged and won a six-month battle to end prior authorization programs for AD medications in three Medicare plans. The skirmish has big implications for future of Medicare formularies— and the balance of power between Big Pharma and managed care.